Mereo Biopharma Group Plc ADR (MREO)

$4.38 +0.03 (0.69%)
Market Cap 530.17M
Revenue (ttm) 10.00M
Net Income (ttm) -29.47M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 28,075
Avg Vol 812,584
Day's Range N/A - N/A
Shares Out 140.26M
Stochastic %K 30%
Beta 0.88
Analysts Strong Sell
Price Target $6.80

Company Profile

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of rare diseases in the United Kingdom and the United States. The company develops Setrusumab, an antibody for the treatment of osteogenesis imperfecta; Alvelestat, an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency associated lung disease; and Vantictumab, an anti-FZD monoclonal antibody for the treatment of autosomal dominant osteope...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 33 3023 7300
Address:
One Cavendish Place, 4th Floor, London, United Kingdom
Antocar
Antocar Sep. 8 at 6:08 AM
$MREO when Reverse Split?
1 · Reply
GamblingFerret
GamblingFerret Sep. 7 at 7:55 PM
$MREO https://www.mereobiopharma.com/news/cantor-global-healthcare-conference/
1 · Reply
Stockflix19
Stockflix19 Sep. 7 at 3:11 PM
$MREO cmon gimmie 3$
1 · Reply
Stockflix19
Stockflix19 Sep. 5 at 7:56 AM
$MREO
0 · Reply
Stockflix19
Stockflix19 Sep. 5 at 7:28 AM
$MREO I entered a position of 50,000 shares at $0.26. I intend to hold for about 12 months, targeting a recovery to the $2.00–$3.00 range.
0 · Reply
douglas98
douglas98 Sep. 4 at 8:49 PM
$MREO called it. Pure trash
0 · Reply
LDT79
LDT79 Sep. 4 at 8:24 PM
$MREO what in the actual fuck - shorts all over the place. fucking hate this stock - never seen such an incompetent bunch
0 · Reply
shhhhKeepItToYourself
shhhhKeepItToYourself Sep. 4 at 5:06 PM
$MREO https://lnkd.in/p/gvB__Hnz
1 · Reply
LDT79
LDT79 Sep. 4 at 2:13 PM
$MREO can’t even go to 30c anymore
1 · Reply
shhhhKeepItToYourself
shhhhKeepItToYourself Sep. 3 at 7:02 PM
$BTC.X Get into $MREO with lot in its pipeline. This is soon going to be $2+ Jump into before shorts start its game
0 · Reply
Latest News on MREO
JPMorgan Downgrades Mereo BioPharma (MREO) Amid Regulatory Concerns, Highlighting Valuation and ...

2026-08-19T14:50:32.000Z - 19 days ago

JPMorgan Downgrades Mereo BioPharma (MREO) Amid Regulatory Concerns, Highlighting Valuation and ...

JPMorgan downgrades Mereo to Underweight on regulatory uncertainty

2026-08-19T13:36:35.000Z - 19 days ago

JPMorgan downgrades Mereo to Underweight on regulatory uncertainty

Mereo BioPharma downgraded to Underweight from Neutral at JPMorgan

2026-08-18T21:40:10.000Z - 20 days ago

Mereo BioPharma downgraded to Underweight from Neutral at JPMorgan

Mereo BioPharma Advances Alvelestat Partnership; Cash Runway Extended Into Late 2027

2026-08-11T17:20:07.000Z - 27 days ago

Mereo BioPharma Advances Alvelestat Partnership; Cash Runway Extended Into Late 2027

Mereo BioPharma Group Releases Q2 2026 Financial Results

2026-08-11T15:18:07.000Z - 27 days ago

Mereo BioPharma Group Releases Q2 2026 Financial Results

Mereo BioPharma (MREO) Advances Alvelestat Program, Faces Valuation Challenges

2026-08-11T13:56:57.000Z - 27 days ago

Mereo BioPharma (MREO) Advances Alvelestat Program, Faces Valuation Challenges

Mereo BioPharma (MREO) Licenses Alvelestat Rights to Sentynl Therapeutics Amid High Valuation ...

2026-08-11T13:42:46.000Z - 27 days ago

Mereo BioPharma (MREO) Licenses Alvelestat Rights to Sentynl Therapeutics Amid High Valuation ...

Mereo BioPharma Licenses Alvelestat Rights To Sentynl Therapeutics

2026-08-11T13:05:09.000Z - 27 days ago

Mereo BioPharma Licenses Alvelestat Rights To Sentynl Therapeutics

Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights

Tue, 11 Aug 2026 08:15:00 -0400 - 27 days ago

Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights

Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)

Tue, 11 Aug 2026 08:00:00 -0400 - 27 days ago

Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)

4basebio Announces Appointment of Chief Financial Officer and Board Changes

Thu, 14 May 2026 07:00:00 -0400 - 3 months ago

4basebio Announces Appointment of Chief Financial Officer and Board Changes

Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Tue, 12 May 2026 07:30:00 -0400 - 3 months ago

Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Class Action Filed Against Mereo BioPharma Group plc (MREO) - April 6, 2026 Deadline to Join – Contact Levi & Korsinsky

Mon, 06 Apr 2026 16:00:00 -0400 - 5 months ago

Class Action Filed Against Mereo BioPharma Group plc (MREO) - April 6, 2026 Deadline to Join – Contact Levi & Korsinsky

MREO DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

Mon, 06 Apr 2026 15:18:00 -0400 - 5 months ago

MREO DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

MREO DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Mon, 06 Apr 2026 13:05:00 -0400 - 5 months ago

MREO DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

MEREO LAWSUIT DEADLINE TODAY: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Regarding Their Rights

Mon, 06 Apr 2026 10:48:00 -0400 - 5 months ago

MEREO LAWSUIT DEADLINE TODAY: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Regarding Their Rights

MREO FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Mon, 06 Apr 2026 09:18:00 -0400 - 5 months ago

MREO FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO

Mon, 06 Apr 2026 03:45:00 -0400 - 5 months ago

Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

Mon, 06 Apr 2026 02:32:00 -0400 - 5 months ago

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

Sun, 05 Apr 2026 16:59:00 -0400 - 5 months ago

MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

MREO DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Sun, 05 Apr 2026 13:00:00 -0400 - 5 months ago

MREO DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

MREO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Sun, 05 Apr 2026 08:18:00 -0400 - 5 months ago

MREO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

MREO DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Sat, 04 Apr 2026 10:59:00 -0400 - 5 months ago

MREO DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Bronstein, Gewirtz & Grossman LLC Urges Mereo BioPharma Group plc Investors to Act: Class Action Filed Alleging Investor Harm

Fri, 03 Apr 2026 12:00:00 -0400 - 5 months ago

Bronstein, Gewirtz & Grossman LLC Urges Mereo BioPharma Group plc Investors to Act: Class Action Filed Alleging Investor Harm

MREO FINAL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

Fri, 03 Apr 2026 11:41:00 -0400 - 5 months ago

MREO FINAL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

MREO Deadline: Rosen Law Firm Urges Mereo BioPharma Group plc (NASDAQ: MREO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Fri, 03 Apr 2026 11:33:00 -0400 - 5 months ago

MREO Deadline: Rosen Law Firm Urges Mereo BioPharma Group plc (NASDAQ: MREO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

MREO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026

Fri, 03 Apr 2026 09:08:00 -0400 - 5 months ago

MREO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026

DEADLINE APPROACHING: Berger Montague Advises BioPharma Group PLC (NASDAQ: MREO) Investors to Inquire About a Securities Fraud Class Action by April 6, 2026

Thu, 02 Apr 2026 12:21:00 -0400 - 5 months ago

DEADLINE APPROACHING: Berger Montague Advises BioPharma Group PLC (NASDAQ: MREO) Investors to Inquire About a Securities Fraud Class Action by April 6, 2026

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

Thu, 02 Apr 2026 10:17:00 -0400 - 5 months ago

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO

Thu, 02 Apr 2026 10:00:00 -0400 - 5 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO

MREO DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Wed, 01 Apr 2026 18:30:00 -0400 - 5 months ago

MREO DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Mereo BioPharma Group plc (MREO) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

Wed, 01 Apr 2026 12:26:00 -0400 - 5 months ago

Mereo BioPharma Group plc (MREO) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

MREO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Wed, 01 Apr 2026 09:50:00 -0400 - 5 months ago

MREO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Shareholders that lost money on Mereo BioPharma Group plc(MREO) should contact Levi & Korsinsky about pending Class Action - MREO

Wed, 01 Apr 2026 09:00:00 -0400 - 5 months ago

Shareholders that lost money on Mereo BioPharma Group plc(MREO) should contact Levi & Korsinsky about pending Class Action - MREO

MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

Tue, 31 Mar 2026 18:37:00 -0400 - 5 months ago

MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

MREO DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

Tue, 31 Mar 2026 17:01:00 -0400 - 5 months ago

MREO DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO

Tue, 31 Mar 2026 15:50:00 -0400 - 5 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO

MEREO BIOPHARMA GROUP PLC (MREO) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by April 6, 2026

Tue, 31 Mar 2026 12:21:00 -0400 - 5 months ago

MEREO BIOPHARMA GROUP PLC (MREO) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by April 6, 2026

MREO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Mereo BioPharma Group plc Securities Lawsuit -- The Gross Law Firm

Tue, 31 Mar 2026 09:00:00 -0400 - 5 months ago

MREO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Mereo BioPharma Group plc Securities Lawsuit -- The Gross Law Firm

MREO FINAL DEADLINE: ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Mon, 30 Mar 2026 22:58:00 -0400 - 5 months ago

MREO FINAL DEADLINE: ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

MREO EQUITY ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Mon, 30 Mar 2026 18:51:00 -0400 - 5 months ago

MREO EQUITY ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

Mon, 30 Mar 2026 10:00:00 -0400 - 5 months ago

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

Mon, 30 Mar 2026 03:43:00 -0400 - 5 months ago

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO

Mon, 30 Mar 2026 03:42:00 -0400 - 5 months ago

Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO

MREO FINAL DEADLINE: ROSEN, LONGSTANDING INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Sun, 29 Mar 2026 22:51:00 -0400 - 5 months ago

MREO FINAL DEADLINE: ROSEN, LONGSTANDING INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

MREO FINAL DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Sat, 28 Mar 2026 22:23:00 -0400 - 5 months ago

MREO FINAL DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

MREO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Sat, 28 Mar 2026 10:03:00 -0400 - 5 months ago

MREO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

MREO FINAL DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Fri, 27 Mar 2026 16:05:00 -0400 - 5 months ago

MREO FINAL DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Bronstein, Gewirtz & Grossman LLC Urges Mereo BioPharma Group plc Investors to Act: Class Action Filed Alleging Investor Harm

Fri, 27 Mar 2026 12:00:00 -0400 - 5 months ago

Bronstein, Gewirtz & Grossman LLC Urges Mereo BioPharma Group plc Investors to Act: Class Action Filed Alleging Investor Harm

MREO Shareholder Alert: Mereo BioPharma Group plc Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm

Fri, 27 Mar 2026 11:03:00 -0400 - 5 months ago

MREO Shareholder Alert: Mereo BioPharma Group plc Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm

Shareholders Sue Mereo BioPharma (MREO) Over Brittle Bone Drug Claims

2026-03-24T11:16:17.000Z - 5 months ago

Shareholders Sue Mereo BioPharma (MREO) Over Brittle Bone Drug Claims

NVS RARE

Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

2026-03-23T09:10:08.000Z - 5 months ago

Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

2026-03-20T20:50:18.000Z - 5 months ago

Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights

Mar 19, 2026, 8:30 AM EDT - 5 months ago

Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights

Stockholders Who Lost Money Investing in Mereo BioPharma Group plc Should Contact Robbins LLP for Information About Recovering Their Losses from MREO

Feb 18, 2026, 2:11 PM EST - 6 months ago

Stockholders Who Lost Money Investing in Mereo BioPharma Group plc Should Contact Robbins LLP for Information About Recovering Their Losses from MREO

Mereo BioPharma sees cash runway into mid-2027

2026-01-12T13:20:17.000Z - 7 months ago

Mereo BioPharma sees cash runway into mid-2027

Mereo BioPharma downgraded to Hold from Buy at Jefferies

2025-12-30T01:50:19.000Z - 8 months ago

Mereo BioPharma downgraded to Hold from Buy at Jefferies

RARE

Mereo BioPharma price target lowered to $1, ‘Fresh Pick’ removed at Baird

2025-12-29T18:50:09.000Z - 8 months ago

Mereo BioPharma price target lowered to $1, ‘Fresh Pick’ removed at Baird

Mereo BioPharma price target lowered to $1 from $6 at BTIG

2025-12-29T18:40:08.000Z - 8 months ago

Mereo BioPharma price target lowered to $1 from $6 at BTIG

Mereo BioPharma downgraded to Market Perform from Outperform at LifeSci Capital

2025-12-29T18:10:09.000Z - 8 months ago

Mereo BioPharma downgraded to Market Perform from Outperform at LifeSci Capital

These biotech stocks are getting hammered by shocking brittle-bone treatment study results

Dec 29, 2025, 1:05 PM EST - 8 months ago

These biotech stocks are getting hammered by shocking brittle-bone treatment study results

RARE

Mereo BioPharma Announces Phase 3 ORBIT and COSMIC Results for Setrusumab (UX143) in Osteogenesis Imperfecta

Dec 29, 2025, 8:31 AM EST - 8 months ago

Mereo BioPharma Announces Phase 3 ORBIT and COSMIC Results for Setrusumab (UX143) in Osteogenesis Imperfecta

āshibio Expands Clinical Pipeline with Vantictumab, a First-In-Class Antibody for Autosomal Dominant Osteopetrosis Type 2

Aug 19, 2025, 8:30 AM EDT - 1 year ago

āshibio Expands Clinical Pipeline with Vantictumab, a First-In-Class Antibody for Autosomal Dominant Osteopetrosis Type 2

Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights

Aug 12, 2025, 7:35 AM EDT - 1 year ago

Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights

Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights

May 13, 2025, 7:30 AM EDT - 1 year ago

Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights

Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights

Mar 26, 2025, 7:30 AM EDT - 1 year ago

Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference

Mar 5, 2025, 7:30 AM EST - 1 year ago

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference

Mereo BioPharma Provides Update on Lead Clinical Programs

Jan 12, 2025, 11:05 AM EST - 1 year ago

Mereo BioPharma Provides Update on Lead Clinical Programs

Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 7, 2025, 7:30 AM EST - 1 year ago

Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference

Nov 14, 2024, 7:30 AM EST - 1 year ago

Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference

Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 12, 2024, 7:30 AM EST - 1 year ago

Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference

Sep 12, 2024, 5:35 PM EDT - 1 year ago

Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference

Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 13, 2024, 8:00 AM EDT - 2 years ago

Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market

Jun 14, 2024, 7:50 AM EDT - 2 years ago

Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market

Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference

May 30, 2024, 7:30 AM EDT - 2 years ago

Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference

Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 15, 2024, 4:01 PM EDT - 2 years ago

Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Apr 3, 2024, 7:30 AM EDT - 2 years ago

Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update

Mar 27, 2024, 4:01 PM EDT - 2 years ago

Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference

Mar 5, 2024, 7:30 AM EST - 2 years ago

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference

Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments

Jan 8, 2024, 7:00 AM EST - 2 years ago

Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments

Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update

Oct 23, 2023, 4:01 PM EDT - 2 years ago

Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update

Antocar
Antocar Sep. 8 at 6:08 AM
$MREO when Reverse Split?
1 · Reply
GamblingFerret
GamblingFerret Sep. 7 at 7:55 PM
$MREO https://www.mereobiopharma.com/news/cantor-global-healthcare-conference/
1 · Reply
Stockflix19
Stockflix19 Sep. 7 at 3:11 PM
$MREO cmon gimmie 3$
1 · Reply
Stockflix19
Stockflix19 Sep. 5 at 7:56 AM
$MREO
0 · Reply
Stockflix19
Stockflix19 Sep. 5 at 7:28 AM
$MREO I entered a position of 50,000 shares at $0.26. I intend to hold for about 12 months, targeting a recovery to the $2.00–$3.00 range.
0 · Reply
douglas98
douglas98 Sep. 4 at 8:49 PM
$MREO called it. Pure trash
0 · Reply
LDT79
LDT79 Sep. 4 at 8:24 PM
$MREO what in the actual fuck - shorts all over the place. fucking hate this stock - never seen such an incompetent bunch
0 · Reply
shhhhKeepItToYourself
shhhhKeepItToYourself Sep. 4 at 5:06 PM
$MREO https://lnkd.in/p/gvB__Hnz
1 · Reply
LDT79
LDT79 Sep. 4 at 2:13 PM
$MREO can’t even go to 30c anymore
1 · Reply
shhhhKeepItToYourself
shhhhKeepItToYourself Sep. 3 at 7:02 PM
$BTC.X Get into $MREO with lot in its pipeline. This is soon going to be $2+ Jump into before shorts start its game
0 · Reply
GamblingFerret
GamblingFerret Sep. 3 at 5:00 PM
$MREO Will be interesting so see if partnering process for Alvelestat in bronchiectasis is ongoing as well. AATD is in everybodys radar, bronchiectasis is no rare disease, could deliver a very nice surprise if partnering gets announced
0 · Reply
shhhhKeepItToYourself
shhhhKeepItToYourself Sep. 3 at 4:09 PM
$RARE Time to jump to $MREO. Make money bcoz it’s going to go $1+ ULTRAGENYX Pharmaceutical RARE and partner, Mereo BioPharma MREO, have reported an update on the progress of the mid-to-late-stage Orbit study, which is evaluating UX143 (setrusumab) for the treatment of osteogenesis imperfecta (OI) in pediatric and young adult patients.
1 · Reply
shhhhKeepItToYourself
shhhhKeepItToYourself Sep. 3 at 4:01 PM
$MREO Let’s gooooo $RARE
0 · Reply
shhhhKeepItToYourself
shhhhKeepItToYourself Sep. 2 at 10:41 PM
All $RARE will be coming to invest in $MREO bcoz that’s there best bet to recover money. It’s there partner. So everyone time to buy this before it goes $0.60 by next week max
2 · Reply
GamblingFerret
GamblingFerret Sep. 2 at 8:39 PM
$MREO Ultrgenyx just released they missed their endpoints in gtx-102, which is a mess for Patients unfortunately… With less assets in the pipeline, the strategic value of Setrusumab increases naturally. They will try even harder to get it over the finish line.
2 · Reply
shhhhKeepItToYourself
shhhhKeepItToYourself Sep. 2 at 6:25 PM
$MREO this is going 0.33+ by end of this week.
2 · Reply
ScottyDoesntKnowMeSon
ScottyDoesntKnowMeSon Sep. 2 at 1:06 PM
$MREO we should pivot to AI data centers
0 · Reply
shhhhKeepItToYourself
shhhhKeepItToYourself Sep. 1 at 7:16 PM
$MREO this is surely popping up soon
1 · Reply
billpap
billpap Sep. 1 at 7:07 PM
$MREO just wait end of the month
1 · Reply
ZK73
ZK73 Sep. 1 at 6:24 AM
$MREO they did not do any dilution, if something changes drastically positively, it can go 8x (~ 2 USD)
1 · Reply
LDT79
LDT79 Aug. 31 at 4:47 PM
$MREO come Fucking traders !!!
0 · Reply
Svetli_stock
Svetli_stock Aug. 31 at 2:55 PM
$MREO 0.4$
0 · Reply